Comparison of Quality-of-Life Instruments in Adults with Strabismus by Hatt, Sarah R. et al.
Comparison of quality of life instruments in adults with
strabismus
Sarah R. Hatt1, David A. Leske1, Elizabeth A. Bradley1, Stephen R. Cole2, and Jonathan M.
Holmes1
1Department of Ophthalmology, Mayo Clinic, Rochester, MN
2 Department of Epidemiology, University of North Carolina at Chapel Hill, NC
Abstract
Purpose—To compare two health-related quality of life (HRQOL) questionnaires in adults with
strabismus: the new AS-20 (developed specifically for adult strabismus) and the NEI VFQ-25
(VFQ-25).
Design—Cross-sectional study
Methods—84 adult patients with strabismus (median age 53, range 18-81 years) completed the
AS-20 and VFQ-25 HRQOL questionnaires. Patients were categorized as diplopic (n=65), or non-
diplopic (n=19). Subnormal HRQOL was defined as below the 5th percentile for adults with no visual
impairment. The proportion of patients below normal was compared overall and by diplopia status.
Results—Overall, more patients scored below normal with the AS-20 than with the VFQ-25 (90%
vs 29%, P <0.0001). Non-diplopic patients were more often below normal on AS-20 psychosocial
subscale than function subscale (95% vs 42%, P=0.002), while diplopic patients were more often
below normal on the function subscale (85% vs 68% and P=0.01). On the psychosocial subscale,
more non-diplopic than diplopic patients scored below normal (95% vs 68%; P=0.01); on the function
subscale more diplopic than non-diplopic patients scored below normal (85% vs 42%; P=0.0005).
The VFQ-25 appeared insensitive to non-diplopic strabismus: no patients scored below normal on
composite score and no more than 11% scored below normal on VFQ-25 subscales. Of diplopic
patients, 37% scored below normal on VFQ-25 composite score. No more than 38% scored below
normal on VFQ-25 subscales.
Conclusion—The new AS-20 appears more sensitive than the VFQ-25 for detecting reduced
HRQOL in adult strabismus, and therefore may be a more useful tool for clinical assessment and
clinical trials.
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Quantitative assessment of health related quality of life (HRQOL) provides a means of
measuring specific effects of strabismus for an individual patient during everyday life. The
NEI-VFQ-25 (VFQ-25) questionnaire1 is commonly used for assessment of HRQOL in many
ophthalmic conditions, but there are few data on the performance of such vision-related
HRQOL instruments in adults with strabismus. Patient-derived, strabismus-specific HRQOL
questionnaires have been recently developed2-4 but there are no data comparing HRQOL
assessment using strabismus-specific questionnaires with assessment using more general
vision questionnaires. We compared quality of life scores using the VFQ-251 questionnaire
and the recently developed Adult Strabismus (AS-20) questionnaire4 to determine which
instrument best detected subnormal HRQOL in adults with strabismus.
Patients and Methods
Institutional Review Board approval was obtained and each patient gave informed consent
before participating. All procedures and data collection were conducted in a manner compliant
with the Health Insurance Portability and Accountability Act.
The AS-20 consists of 20 questions with 2 established subscales: Psychosocial (10 items) and
Function (10 items).4 For each AS-20 questionnaire item a 5-point Likert type scale is used
for responses: ‘never’ (score 100), ‘rarely’ (score 75), ‘sometimes’ (score 50), ‘often’ (score
25), and ‘always’ (score 0).4 The VFQ-25 consists of 25 questions in 12 subscales: General
health, General vision, Ocular pain, Near activities, Distance activities, Vision specific social
function, Vision specific mental health, Vision specific role difficulties, Vision specific
dependency, Driving, Color vision and Peripheral vision. As described in the instructions
outlined in the manuscript first describing the VFQ-25,1 composite scores were calculated from
all subscales with the exception of the ‘General Health’ subscale. Different response options
are used depending on the question (full questionnaire with user instructions available at:
http://www.nei.nih.gov/resources/visionfunction/vfq_ia.pdf; accessed 23rd February 2009).
For AS-20 and VFQ-25 questionnaires, scores range from 0 (worst HRQOL), to 100 (best
HRQOL) overall and on predefined subscales.
Normal thresholds
For the purposes of this study we defined subnormal AS-20 and VFQ-25 scores as those below
the 5th percentile for visually normal adults. To determine whether alternative definitions of
subnormal would influence our findings, we also performed a secondary analysis setting
thresholds using 1.96 standard deviations (SD) below mean values for normal non-strabismic
adults for both VFQ-25 and AS-20. Using 1.96SD below the mean assumes a Gaussian
distribution of the data but HRQOL data in a visually normal population do not follow a
Gaussian distribution. Nevertheless, some available datasets only provide mean and SD data,
and so percentiles cannot be calculated.
For the VFQ-25 questionnaire, we used previously published normative data, from studies by
Varma et al5 and Mangione et al.1 For the percentile analysis we used individual scores, made
available to us by Varma et al, on 1000 randomly selected, English speaking adults with no
visual impairment (from the 4272 published in their manuscript5). We performed two
secondary analyses, calculating normal thresholds as the mean minus 1.96 SD from: 1) data
provided by Varma et al and 2) the published report by Mangione et al. Because the Mangione
report did not include the composite VFQ-25 score, we computed a mean (SD) composite score
as the mean of all the sub-scales with the exception of the General Health subscale as described
in the VFQ-25 instructions.1 Derived normal thresholds for VFQ-25 composite score and for
each of the VFQ-25 subscales are shown in Table 1.
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For the AS-20 questionnaire there were limited previously published normative data.
Therefore, we calculated the 5th percentile from 31 visually-normal adults (median age 45,
range 23 to 63 years). For the secondary analyses we calculated the normal threshold for the
AS-20 using the mean minus 1.96SD from the same group of 31 visually normal adults.
Nineteen (61%) were female and for 29 (94%) race was self-reported as ‘White.’ All subjects
had no history of strabismus or amblyopia and underwent a full orthoptic examination. All
were orthotropic at distance and near fixation, and had no more than 10 pd of horizontal phoria
and no vertical heterophoria by prism and alternate cover test. Stereoacuity was 40 seconds of
arc using the Frisby test, and best corrected visual acuity was at least 20/25 in each eye (median
20/20 in each eye). Of these 31 visually normal adults, data on 13 have been reported
previously.4 Derived normal thresholds for AS-20 composite score and for AS-20 subscales
are shown in Table 1.
Patients
Ninety-six adults with strabismus (median 50.5, range 18-81 years) were prospectively
recruited from outpatient clinics to complete the AS-20 and VFQ-25 HRQOL questionnaires.
Patients were classified as ‘diplopic,’ ‘non-diplopic’ or ‘rare diplopia’ based on their history
and clinical exam. The 12 patients classified as ‘rare diplopia,’ reported vague symptoms of
occasional diplopia. For the purposes of this present study these patients were excluded from
further analysis because our goal was to determine whether the questionnaires would
discriminate between patients with and without true binocular diplopia. Of the 84 remaining
patients, 65 were classified as diplopic and 19 as non-diplopic. 42 (50%) had undergone
strabismus surgery historically (at least one year prior to assessment), and had residual or
consecutive strabismus at the time of assessment.
Patients completed AS-20 and VFQ-25 questionnaires without assistance during the office
visit, following simple verbal and written instructions.4
(http://www.nei.nih.gov/resources/visionfunction/vfq_ia.pdf; accessed 23rd February 2009).
For both questionnaires, written instructions indicated that the patient should answer each
question based on their visual experience with habitual refractive correction in place, including
any prism correction if this was worn habitually (26 (40%) of 65 diplopic patients). For the
purposes of standardization, patients were asked to complete the AS-20 questionnaire first,
followed by the VFQ-25.
Patients with diplopia
Of the 65 patients with diplopia 27 had neurogenic strabismus, 27 childhood onset / idiopathic
strabismus, 10 had mechanical strabismus and 1 sensory strabismus. Twenty patients had a
primary esodeviation; 24 patients had a primary exodeviation, 17 had a primary vertical
deviation, and 4 were orthophoric in primary position following surgery over 1 year previously
but had residual strabismus in eccentric gaze positions. Visual acuity ranged from 20/15 to
20/40 (median 20/20) in the better eye and from 20/15 to 20/80 (median 20/25) in the worst
eye. 12 (18%) of 65 patients had ocular co-morbidity such as cataract, glaucoma or previous
retinal detachment.
Patients without diplopia
Of the 19 patients without diplopia, 14 had childhood onset / idiopathic strabismus, 3 had
sensory strabismus and 2 neurogenic strabismus. Two patients had a primary esodeviation; 15
patients had a primary exodeviation, and two had a primary vertical deviation. Visual acuity
ranged from 20/15 to 20/40 (median 20/20) in the better eye and from 20/20 to 20/800 (median
20/30) in the worst eye. Five (26%) of 19 patients had ocular co-morbidity such as cataract,
glaucoma or previous retinal detachment.
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For each patient, on each questionnaire, mean composite and subscale scores were calculated.
The calculated normal thresholds are shown in Table 1. The lowest thresholds were found using
the 5th percentile of the data provided by Varma and the highest using 1.96SD below the mean
of the Mangione data. We therefore used these two extremes to calculate the proportion of
subjects falling below defined normal thresholds across all patients and for sub-groups of
patients with and without diplopia. The proportion of patients with below normal scores using
the AS-20 was compared to the proportion of patients with below normal scores using the
VFQ-25 with McNemar's tests. Proportions of below normal scores for patients with and
without diplopia were compared using Fishers exact tests.
Results
Proportions of subnormal scores using 5th percentile threshold
All strabismus patients—More patients scored below normal on AS-20 than VFQ-25
composite scores (90% vs 29%; P<0.0001, Table 2). On AS-20 subscales, 74% scored below
normal on the Psychosocial subscale and 75% on the Function subscale (Table 2). The VFQ-25
subscales with the highest proportion of subnormal scores were: Driving (32%), Distance
activities (25%) and Vision specific role difficulties (21%) (Table 2).
Patients with diplopia—Of the 65 patients with diplopia, significantly more scored below
normal on AS-20 composite score than on the VFQ-25 composite score (89% vs 37%,
P<0.0001, Table 2). 85% of diplopic patients scored below normal on the AS-20 Function
subscale and 68% on the Psychosocial subscale (P=0.01, Table 2). Of VFQ-25 subscales, the
highest proportion of subnormal scores were: Driving (38%), Distance activities (31%) and
Vision specific role difficulties (28%) (Table 2).
Patients without diplopia—Of the 19 patients without diplopia significantly more scored
below normal on the AS-20 composite score than on the VFQ-25 composite score (95% vs
0%, Table 2). 95% of non-diplopic patients scored below normal on the AS-20 Psychosocial
subscale and 42% on the AS-20 Function subscale (P=0.002, Table 2). Non-diplopic patients
very rarely scored below normal on any of the VFQ-25 sub scales: the highest proportion of
below normal scores was 11% on the Driving subscale and General health subscales (Table
2).
Comparison between patients with and without diplopia—On the AS-20
questionnaire, composite scores were comparable between diplopic and non-diplopic patients
(Table 2). Nevertheless more non-diplopic than diplopic patients scored below normal on the
Psychosocial subscale (95% vs 68%; P=0.01, Table 2) whereas more diplopic than non-
diplopic patients scored below normal on the Function subscale (85% vs 42%; P=0.0005, Table
2). On the VFQ-25, more diplopic than non-diplopic patients scored below normal on the
composite score (37% vs 0%; P=0.001, Table 2). More diplopic patients also scored below
normal on 5 of the 11 subscales (Distance activities, Vision specific mental health, Vision
specific role difficulties, Driving and Peripheral vision) (Table 2). There were no VFQ-25
subscales where non-diplopic patients scored below normal more often than diplopic patients.
Secondary analysis - proportions of subnormal scores using mean minus 1.96SD threshold
Using thresholds based on the mean minus 1.96 SD (Mangione et al VFQ-25 data and normal
AS-20 data), we found very similar results to those obtained using the 5th percentile to define
normal thresholds (Table 2). More patients (overall, diplopic and non-diplopic) scored below
normal on the AS-20 than on the VFQ-25, on composite scores and on subscales.(Table 2).
Hatt et al. Page 4














Both AS-20 and VFQ-25 questionnaires detected reduced HRQOL in adults with strabismus.
The patient-derived, strabismus-specific AS-20 questionnaire detected subnormal HRQOL
more often than the vision-specific VFQ-25 questionnaire. The AS-20 questionnaire and
component subscales (Psychosocial and Function) were better able to detect the impact of
strabismus on HRQOL, in patients both with and without diplopia.
Our finding that more patients scored below normal thresholds using the AS-20 than using the
VFQ-25 suggests that the strabismus-specific AS-20 is better able to detect reduced HRQOL
in adults with strabismus. This greater sensitivity of the AS-20 to the effects of strabismus may
have been predicted given the expectation that condition-specific questionnaires address
HRQOL concerns specific to the condition of interest.6, 7 Future studies evaluating other
aspects of validity such as test retest reliability and responsiveness (e.g. following treatment)
will further help confirm the usefulness of these HRQOL instruments for clinical evaluation
of adult strabismus.
The VFQ-25 questionnaire was more sensitive to the effects of strabismus in patients with
diplopia than in those without diplopia. It is likely that this finding reflects the VFQ-25
emphasis on vision deficits in contrast to psychosocial concerns. There are few previous data
on the performance of the VFQ-25 in adults with strabismus, but a study by Bradley et al8
reported patients with Graves eye disease with diplopia scored lower (worse HRQOL) on the
VFQ-25 than those with Graves disease but without diplopia, and presumably, also without
strabismus. In our present study, VFQ-25 subscales such as Driving, Distance Activities and
Vision specific role difficulties appeared somewhat sensitive to diplopic strabismus, but not
non-diplopic strabismus. Nevertheless, the proportion of subnormal scores was greater using
the AS-20, both Psychosocial and Function subscales detecting reduced HRQOL in strabismus
patients with and without diplopia. Interestingly, specific topic areas in the VFQ-25 such as
Driving, which are not covered in the AS-20, did not yield a very high proportion of below
normal responses in this study population (32% overall, and 38% in patients with diplopia).
This finding supports our previous decision, during the development of the AS-20, to exclude
questions regarding driving.4
The two established subscales of the AS-20 (Function and Psychosocial)4 appeared to
discriminate well between patients with and without diplopia in the present study. As might
be expected based on clinical experience, significantly more diplopic than non-diplopic
patients scored below normal on the function subscale (85% vs 42%; P=0.0004, Table 2) and
significantly more non-diplopic than diplopic patients scored below normal on the psychosocial
subscale (95% vs 68%; P=0.02, Table 2). Nevertheless, as noted in our previous report,4 while
impact on function appears predominant for diplopic patients, the majority also report
psychosocial concerns. Similarly, while psychosocial concerns dominate for non-diplopic
patients, a large proportion also report impact on function. Identifying the type of HRQOL
concerns present for an individual patient may be important in their clinical management.
There are several limitations to this study. First, the VFQ-25 was designed to measure HRQOL
in adults with reduced visual acuity due to eye disease such as cataract, potentially making it
more likely to detect reduced HRQOL in the few patients in our study who had reduced visual
acuity. Nevertheless, such an effect would make the VFQ-25 more rather than less sensitive
to reduced HRQOL, strengthening our finding of better detection of reduced HRQOL using
the AS-20. Another limitation is that we recruited a relatively small number of non-diplopic
patients. Nevertheless, it is noteworthy that the observed difference was large enough that we
were still able to demonstrate statistically significant differences between proportions scoring
below normal. Also, we defined normal thresholds on the AS-20 using a relatively small
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number of racially homogeneous, visually normal adults, but the AS-20 normal thresholds
based on the 5th percentile and the mean minus 1.96SD were very similar. An additional
potential limitation is that our primary analysis is based on Latino visually normal adults,5 but
secondary analysis using a presumably different racial group1 yielded similar results.
The new strabismus-specific, patient-derived AS-20 questionnaire is more sensitive than the
VFQ-25 for detecting reduced HRQOL in adults with strabismus and discriminates between
patients with and without diplopia. Further studies are needed to evaluate relationships between
severity of strabismus and these measures of HRQOL.
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